Eris Lifesciences takes ₹45 crore ($4.7M) term loan from Axis Bank
What's the deal? Eris Lifesciences has secured a ₹45 crore (roughly $4.7 million) term loan from Axis BankDealroom has a profile for this one. Try Dealroom →, under an agreement executed on September 9, 2026. Axis Bank takes a charge on the company's brands as security for the loan.
Why now? The company describes the loan as a routine measure to manage its financial obligations. It does not expect the facility to alter its net debt figure at the end of the current quarter.
What's the endgame? Eris Lifesciences frames the loan as an adjustment to its broader financial structure rather than fresh capital for expansion. Pledging its brands as collateral signals it is tapping the value of its portfolio to support that structure.
The signal: A brand-secured term loan that leaves net debt unchanged points to balance-sheet housekeeping rather than a bet on growth — the kind of quiet financing move that rarely makes headlines but keeps a company's obligations in order.
Read more: investywise.com
Image credit: Monash Public Library Service
